Quantcast

Panel changes position on PSA test for prostate cancer - WCAX.COM Local Vermont News, Weather and Sports-

Panel changes position on PSA test for prostate cancer

Posted: Updated:
NEW YORK -

Larry Blumberg's life changed when his doctor diagnosed him with prostate cancer last year.

"It was very upsetting, but he also said we are in time. I'm not sure if we could have been in time if we had done this a year or two from now," Blumberg said.

The 69-year-old's cancer was detected after Blumberg opted to have a PSA blood test, even though he had no symptoms and the screening was not recommended by the U.S. Preventive Services Task Force.

Now, based on the latest research, the group says men 55-69 should have a conversation with their doctor and make a decision for themselves.

"Men can reduce their chance of dying of prostate cancer and reduce their chance of having cancer that spreads throughout their body. These are really important benefits but they occur in a small number of men," said Dr. Kirsten Bibbins-Domingo, the chair of the U.S. Preventive Services Task Force.

The concern has been that PSA testing results in overtreating cancers, which can lead to serious issues like impotence and incontinence.

Dr. Herbert Lepor says advances in detection and closely monitoring low-risk cancers are helping men avoid drastic treatment.

"We have the tools today so we can decrease men who will undergo unnecessary biopsy, better tools to assess aggressiveness and more innovative therapies," Lepor said.

Blumberg needed surgery to remove his prostate. He's had some side effects but says they are getting better.

"The side effects are nothing compared to the fact that I'm going to live a long life, enjoy my kids and my grandchildren," Blumberg said.

Blumberg is cancer-free and his PSA is undetectable.

Powered by Frankly
All content © Copyright 2000 - 2017 WCAX. All Rights Reserved. For more information on this site, please read our Privacy Policy, and Terms of Service, and Ad Choices.